Analyst Coverage Initiated: MNMD rating Buy by ROTH Capital
Price Target: $7
Report Date: 05-04-2022
Symbol: MNMD - Mind Medicine (MindMed) Inc.
Sector: Healthcare
Industry: Biotechnology
Analyst Coverage Initiated: MNMD rating Buy by ROTH Capital
Price Target: $7
Mind Medicine (MindMed) Inc. (MNMD)
One World Trade Center
New York, NY 10007
Phone:
Website: https://www.mindmed.co
CEO: Mr. Jamon Alexander Rahn
NASDAQ, Nasdaq Global Select
Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.
stock trading signals, free stock market signals, daily stock signals, free stock trading signals
Good stock signals have been found on this server. That is all we know.
+1 (407) 559-7228